The Plasmax Concentrate Advantage

Through a simple process, the Plasmax System produces a fully autologous plasma concentrate with elevated fibrinogen concentration that is optimal for haemostasis.1-2


  • Autologous Therapies


  • Biologics


  • Multiple

Produces elevated fibrinogen concentration optimal for haemostasis and bone grafting handling.1-2

Fibrinogen concentration



System Features

The Plasmax Plasma Concentration System is comprised of two distinct parts, the GPS III Separator and the Plasmax Concentrator. The GPS III Separator produces leukocyte-rich platelet-rich plasma (L-PRP) from a small sample of the patient’s own blood. The Plasmax Concentrator produces autologous fibrinogen-rich platelet-poor plasma concentrate (PPPc)* utilizing polyacrylamide beads to remove excess water.

Features of the system include:

  • Outputs up to 10 cc of rapidly polymerizing autologous plasma concentrate3
  • Outputs up to 3 or 6 cc of PRP, depending on which GPS III kit is being used
  • Produces both outputs in less than 20 minutes
  • Autologous outputs eliminate concern regarding pooled blood sources
*Autologous output from the Plasmax Plasma Concentration System eliminates concern regarding pooled blood sources. Pooled plasma sources found in donor-based fibrin sealants carry the risk of transmitting infectious diseases and viruses.


Consistent Results

  • Clinically proven GPS technology1

Improves Haemostasis

  • Provides between 1.5 and 4 increase in fibrinogen concentration2


  • A 100% autologous plasma concentrate – provides a natural haemostatic alternative

Instructions for Use

  • Contains all items needed to process quality plasma concentrate in two minutes

Additional Information

Tailored resources for your patients.

Find videos, articles, and interactive content to guide your patients throughout their surgical journey on, our dedicated patient recovery site.